...
首页> 外文期刊>Cytopathology >Do anticoagulation medications increase the risk of haematoma in ultrasound‐guided fine needle aspiration of thyroid lesions?
【24h】

Do anticoagulation medications increase the risk of haematoma in ultrasound‐guided fine needle aspiration of thyroid lesions?

机译:抗凝药物是否会增加甲状腺病变的超声引导细小针头中血肿的风险?

获取原文
获取原文并翻译 | 示例
           

摘要

Background A feared complication of thyroid fine needle aspiration ( FNA ) is bleeding diathesis and haematoma at the biopsy site. Patients are often advised to discontinue antithrombotic/anticoagulant ( AT / AC ) medications prior to the procedure. The aim of this study was to examine the risk of bleeding in patients on AT / AC medications undergoing cervical ultrasound ( US )‐guided FNA . Methods A retrospective chart review of 803 patients who underwent US ‐guided FNA of thyroid nodules over 8?years by a single endocrine surgeon was undertaken. Clinical variables, patient demographics and use of AT / AC medications were collected and analysed. The principle outcome measures included the incidence of procedure‐related haematoma formation. Multivariable logistic regression was used to investigate the possible independent association between post‐ FNA haematoma and anticoagulation, adjusting for age, African American race, body mass index, vascularity and lesion size. Results A total of 1568 lesions were included in 803 patients. The mean age for the patients on AT / AC was 63.0?±?10.4?years and those not on AT / AC was 50.1?±?14.2?years ( P ??0.001). Of those, 148 patients had 336 lesions (21%) biopsied while taking one or more daily AT / AC agent (81 patients: aspirin; 11 patients: Plavix; 17 patients: aspirin and warfarin; 30 patients: aspirin and Plavix; seven patients: rivaroxaban and aspirin; and two patients: ticagrelor and aspirin). Three patients (0.89%) in the AT / AC group compared to six patients (0.49%) not receiving AT / AC medications developed a haematoma ( P ?=?0.41). All complications were treated conservatively and none required intervention. Conclusions US ‐guided FNA of thyroid lesions can be safely performed on patients taking AT / AC including newer agents, without an increase in adverse outcomes or decreased diagnostic rate. Further larger prospective multi‐institutional studies are warranted to further investigate this important finding.
机译:背景技术甲状腺细针吸入(FNA)的恐惧并发症是活组织检查部位的血液素质和血肿。通常建议患者在程序之前停止抗血栓形成/抗凝血剂(AT / AC)药物。本研究的目的是探讨患者患者出血的风险,患有宫颈超声(US) - 帘FNA的AT / AC药物。方法对803例甲状腺结节的甲状腺结节的患者进行了回顾性图表综述,通过单一内分泌外科医生进行了超过8岁。收集和分析临床变量,患者人口统计学和AT / AC药物的使用。原理结果措施包括与程序相关的血肿形成发生率。使用多变量的逻辑回归来研究血肿和抗凝后可能的独立关联,调整年龄,非洲裔美国人的种族,体重指数,血管性和病变大小。结果803名患者共有1568例病变。 AT / AC患者的平均年龄为63.0?±10.4?年份,那些不在/ Ac上的那些是50.1?±14.2?岁(p?& 0.001)。其中148名患者有336名病变(21%)活检,同时服用一次或多次AT / AC试剂(81例:阿司匹林:11名患者:Plavix; 17例:阿司匹林和华法林; 30名患者:阿司匹林和Plavix; 7名患者:Rivaroxaban和阿司匹林;和两名患者:Ticagrelor和Aspirin)。在AT / AC组中的三名患者(0.89%)与六名患者(0.49%)(0.49%)未接受/ AC药物发育血肿(P?= 0.41)。所有并发症均得到保守,无需干预。结论可以安全地对甲状腺病变的US -guided FNA对AT / AC包括更新剂的患者进行安全进行,而不会增加不利结果或降低诊断率。进一步更大的预期多机构研究是有必要进一步调查这一重要发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号